NL-OMON40449已完成不适用
Adipose Tissue Imaging in Patients with Type 2 Diabetes, Pilot Study - AT imaging in T2D, pilot
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age>= 18 years
- •For healthy volunteers: Fasting blood glucose< 6.1 mmol/l, HbA1c< 42 mmol/mol (6%)
- •For patients with T2D: Clinical overt T2D, on a glucose-lowering diet or on oral glucose-lowering medication, stable and under control for minimal 2 years, HbA1c< 75 mmol/mol (9%)
排除标准
- •Renal dysfunction with MDRD< 60
- •Overt symptomatic neuropathy or proliferative retinopathy
- •A history of cardiovascular disease complications (myocardial infarction, stroke, peripheral artery disease)
- •Pregnancy or lactating
- •Receiving subcutaneous insulin
- •Incapability to provide informed consent
研究者
相似试验
已完成
不适用
Adipose Tissue Imaging in Type 2 DiabetesDiabetes Mellitus Type 2NCT02528695Radboud University Medical Center15
Unknown
不适用
Adipose Tissue Dysfunction in Type 2 Diabetes and Its Reversibility by Bariatric SurgeryAdipose Tissue Dysfunction Type 2 Diabetes Mellitus Bariatric SurgeryNCT05291013Odense University Hospital45
终止
不适用
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinType 2 DiabetesNCT00159211Assistance Publique - Hôpitaux de Paris28
进行中（未招募）
1 期
Kidney Fat in Type 2 Diabetes and the Effects of EzetimibeType 2 diabetes, diabetic kidney diseaseMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861MedDRA version: 21.1Level: LLTClassification code 10045250Term: Type II diabetes mellitus with renal manifestationsSystem Organ Class: 100000004857EUCTR2020-001155-40-DKSteno Diabetes Center Copenhagen120
尚未招募
不适用
Study of serum adiponectin levels in type2 diabetes mellitus patients on treatmentCTRI/2022/01/039750kasturba medical college